Concentra [CON] vs Option Care Health [OPCH] Detailed Stock Comparison
Concentra
NYSE
Loading...
Option Care Health
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Concentra wins in 10 metrics, Option Care Health wins in 8 metrics, with 0 ties. Concentra appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Concentra | Option Care Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 14.92 | 24.10 | Concentra |
| Price-to-Book Ratio | 8.53 | 3.65 | Option Care Health |
| Debt-to-Equity Ratio | 645.86 | 90.53 | Option Care Health |
| PEG Ratio | 16.35 | 23.90 | Concentra |
| EV/EBITDA | 12.37 | 14.93 | Concentra |
| Profit Margin (TTM) | 8.10% | 4.12% | Concentra |
| Operating Margin (TTM) | 16.73% | 5.94% | Concentra |
| EBITDA Margin (TTM) | 16.73% | 5.94% | Concentra |
| Return on Equity | 20.93% | 15.38% | Concentra |
| Return on Assets (TTM) | 7.69% | 6.33% | Concentra |
| Free Cash Flow (TTM) | $210.35M | $287.79M | Option Care Health |
| Dividend Yield | 0.57% | N/A | N/A |
| 1-Year Return | -9.93% | -3.07% | Option Care Health |
| Price-to-Sales Ratio (TTM) | 1.36 | 0.95 | Option Care Health |
| Enterprise Value | $4.69B | $5.92B | Option Care Health |
| EV/Revenue Ratio | 2.42 | 1.14 | Option Care Health |
| Gross Profit Margin (TTM) | 28.69% | 19.73% | Concentra |
| Revenue per Share (TTM) | $16 | $31 | Option Care Health |
| Earnings per Share (Diluted) | $1.37 | $1.25 | Concentra |
| Beta (Stock Volatility) | N/A | 0.73 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Concentra vs Option Care Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Concentra | 0.99% | 1.19% | -0.83% | -6.21% | -13.01% | 5.75% |
| Option Care Health | 1.69% | 1.66% | -5.67% | -5.17% | -2.42% | 34.98% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Concentra | -9.93% | -10.76% | -10.76% | -10.76% | -10.76% | -10.76% |
| Option Care Health | -3.07% | -11.16% | 153.85% | 185.82% | 68.72% | 15.36% |
Performance & Financial Health Analysis: Concentra vs Option Care Health
| Metric | CON | OPCH |
|---|---|---|
| Market Information | ||
| Market Cap | $2.62B | $4.93B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 714,087 | 1,147,181 |
| 90 Day Avg. Volume | 889,272 | 1,436,217 |
| Last Close | $20.40 | $30.64 |
| 52 Week Range | $18.89 - $24.81 | $21.39 - $35.53 |
| % from 52W High | -17.76% | -13.76% |
| All-Time High | $24.81 (Sep 02, 2024) | $91.80 (Apr 22, 2002) |
| % from All-Time High | -17.78% | -66.62% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.07% | 0.16% |
| Quarterly Earnings Growth | -0.21% | 0.04% |
| Financial Health | ||
| Profit Margin (TTM) | 0.08% | 0.04% |
| Operating Margin (TTM) | 0.17% | 0.06% |
| Return on Equity (TTM) | 0.21% | 0.15% |
| Debt to Equity (MRQ) | 645.86 | 90.53 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $2.40 | $8.25 |
| Cash per Share (MRQ) | $0.41 | $1.09 |
| Operating Cash Flow (TTM) | $241.75M | $384.96M |
| Levered Free Cash Flow (TTM) | $144.30M | $294.96M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.57% | N/A |
| Last 12-Month Dividend | $0.12 | N/A |
Valuation & Enterprise Metrics Analysis: Concentra vs Option Care Health
| Metric | CON | OPCH |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 14.92 | 24.10 |
| Forward P/E | 16.35 | 23.90 |
| PEG Ratio | 16.35 | 23.90 |
| Price to Sales (TTM) | 1.36 | 0.95 |
| Price to Book (MRQ) | 8.53 | 3.65 |
| Market Capitalization | ||
| Market Capitalization | $2.62B | $4.93B |
| Enterprise Value | $4.69B | $5.92B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.42 | 1.14 |
| Enterprise to EBITDA | 12.37 | 14.93 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.73 |
| Book Value per Share (MRQ) | $2.40 | $8.25 |
Financial Statements Comparison: Concentra vs Option Care Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CON | OPCH |
|---|---|---|
| Revenue/Sales | $500.75M | $1.33B |
| Cost of Goods Sold | $357.10M | $1.07B |
| Gross Profit | $143.65M | $263.05M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $80.32M | $79.19M |
| EBITDA | $96.94M | $93.16M |
| Pre-Tax Income | $53.90M | $63.56M |
| Income Tax | $13.25M | $16.81M |
| Net Income (Profit) | $40.64M | $46.74M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CON | OPCH |
|---|---|---|
| Cash & Equivalents | $52.11M | $171.37M |
| Total Current Assets | $351.59M | $1.10B |
| Total Current Liabilities | $320.39M | $713.66M |
| Long-Term Debt | $2.02B | $1.19B |
| Total Shareholders Equity | $331.06M | $1.35B |
| Retained Earnings | $44.45M | $716.08M |
| Property, Plant & Equipment | $670.30M | $129.57M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CON | OPCH |
|---|---|---|
| Operating Cash Flow | $36.49M | $-46.97M |
| Capital Expenditures | $-15.73M | $-9.37M |
| Free Cash Flow | $-4.03M | $-16.59M |
| Debt Repayment | $-852.57M | $-1.63M |
| Common Stock Repurchase | N/A | $-100.22M |
Short Interest & Institutional Ownership Analysis
| Metric | CON | OPCH |
|---|---|---|
| Shares Short | 2.55M | 4.70M |
| Short Ratio | 2.61 | 2.97 |
| Short % of Float | 0.03% | 0.04% |
| Average Daily Volume (10 Day) | 714,087 | 1,147,181 |
| Average Daily Volume (90 Day) | 889,272 | 1,436,217 |
| Shares Outstanding | 128.13M | 166.26M |
| Float Shares | 115.36M | 154.38M |
| % Held by Insiders | 0.10% | 0.01% |
| % Held by Institutions | 0.85% | 1.04% |
Dividend Analysis & Yield Comparison: Concentra vs Option Care Health
| Metric | CON | OPCH |
|---|---|---|
| Last 12-Month Dividend | $0.12 | N/A |
| Last 12-Month Dividend Yield | 0.57% | N/A |
| 3-Year Avg Annual Dividend | $0.04 | N/A |
| 3-Year Avg Dividend Yield | 0.30% | N/A |
| 3-Year Total Dividends | $0.12 | N/A |
| Ex-Dividend Date | Mar 18, 2025 | N/A |